Robert Ramirez, DO, FACP
- Sr Physician, Kenner Region
- 200 W Esplanade, Kenner, LA, 70065
For additional information or to make an appointment, click here.
Overview
Overview
- Dr. Ramirez earned his medical degree from the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine. He completed an internal medicine residency at Cooper University Hospital in Camden, New Jersey. He then completed a combined hematology and medical oncology fellowship at the University of Tennessee Health Sciences Center in Memphis, Tennessee where he served as chief fellow. He is board certified in medical oncology and internal medicine. He is a Fellow of the American College of Physicians (FACP) and a member of American Society of Clinical Oncology (ASCO), International Association for the Study of Lung Cancer (IASLC), and the North American Neuroendocrine Tumor Society (NANETS). He has clinical and research interests in lung cancer, specifically non-small cell and small cell cancers as well as neuroendocrine tumors of the lung including DIPNECH, typical and atypical carcinoids. He has given multiple presentations at National and International meetings on the topics of lung cancer and neuroendocrine tumors and has multiple peer reviewed publications. He is a recognized thought leader in these fields. He splits his clinical and research duties between the Ochsner Lung Cancer Multidisciplinary Program and the Ochsner Kenner/LSU Multidisciplinary Neuroendocrine Clinic. He is active in clinical trial design as well as teaching to fellows, residents and medical students. Dr. Ramirez's clinical interests include: Non-small cell lung cancer, small cell lung cancer, neuroendocrine tumors of the lung, DIPNECH and neuroendocrine tumors of the GI tract.
Publications
Selected publications
-
2021The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers. Journal of Thoracic Oncology. 16:S879-S879.
-
2020Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines. Journal of Thoracic Oncology. 15:1577-1598.
-
2020Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines. Journal of Thoracic Oncology. 15:1577-1598.
-
2020Management of Appendiceal Neuroendocrine Tumors: Metastatic Potential of Small Tumors. Annals of Surgical Oncology.
-
2020Management of Appendiceal Neuroendocrine Tumors: Metastatic Potential of Small Tumors. Annals of Surgical Oncology. 27:S57-S57.
-
2020Surgical Management of Metastatic Pancreatic Neuroendocrine Tumors at a Single Institution: Effect of Patient and Tumor Characteristics on Clinical Outcomes. Annals of Surgical Oncology. 27:S56-S56.
-
2019A Phase II Trial of Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Neuroendocrine Carcinoma. Journal of Thoracic Oncology. 14:S813-S814.
-
2019Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma. Oncologist. 24:1076-1088.
-
2019Does the addition of adjuvant intraoperative tumor bed chemotherapy during midgut neuroendocrine tumor debulking procedures benefit patients?. JOURNAL OF GASTROINTESTINAL ONCOLOGY. 10:928-934.
-
2019Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis. Journal of Oncology Pharmacy Practice. 25:1425-1433.
-
2019Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors. JOURNAL OF GASTROINTESTINAL ONCOLOGY. 10:674-687.
-
2019Molecular Characteristics of Small-Bowel Neuroendocrine Tumors. Pancreas. 48:435-435.
-
2019NET-001: A Phase II Study of ABI-009 in Metastatic Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System. Journal of Thoracic Oncology. 14:S1023-S1023.
-
2019Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids. Clinical Lung Cancer. 20:E376-E392.
-
2018Optimal cut points for Ki-67 proliferative index in predicting survival in high grade neuroendocrine tumors.. Journal of Clinical Oncology. 36.
-
2018Pulmonary Neuroendocrine (Carcinoid) Tumors: CommNETs/NANETS Endorsement and Update of the ENETs Best Practice Consensus. Journal of Thoracic Oncology. 13:S575-S575.
-
2018Quality of life for non-small cell lung cancer patients in the age of immunotherapy. TRANSLATIONAL LUNG CANCER RESEARCH. 7:S149-S152.
-
2018Surgical Management of Appendiceal NETs: Does Size Matter?. Annals of Surgical Oncology. 25:S20-S20.
-
2018The role of Ki-67 in determining optimal chemotherapy in high grade neuroendocrine tumors.. Journal of Clinical Oncology. 36.
-
2018Utility of Stereotactic Body Radiotherapy in Pulmonary Carcinoid Tumors. Journal of Thoracic Oncology. 13:S793-S793.
-
2017Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single Institution. Journal of The American College of Surgeons. 224:434-447.
-
2017
-
2017From the Guest Editor: The Rapidly Changing Field of Cancer Treatment. The Ochsner Journal. 17:304-304.
-
2017Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy. The Ochsner Journal. 17:362-378.
-
2017
-
2017Management of pulmonary neuroendocrine tumors. Reviews in Endocrine and Metabolic Disorders. 18:433-442.
-
2017Molecular Targets in Non-Small Cell Lung Cancer. The Ochsner Journal. 17:388-392.
-
2017Prognostic Factors in Typical and Atypical Pulmonary Carcinoids. The Ochsner Journal. 17:335-340.
-
2017The Role of Checkpoint Inhibition in Non-Small Cell Lung Cancer. The Ochsner Journal. 17:379-387.
-
2016Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum. Journal of The American College of Surgeons. 222:534-542.
-
2016Liver needle biopsies and prediction of histologic tumor grade for midgut neuroendocrine tumors.. Journal of Clinical Oncology. 34.
-
2016Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer. Annals of Thoracic Surgery. 102:448-453.
-
2016The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors. Oncologist. 21:671-675.
-
2015Clinical and Pathologic Characteristics of Bronchial Carcinoid Tumors: A Single Institution Review. Journal of Thoracic Oncology. 10:S749-S750.
-
2015Radionuclide Therapy with Meta-Iodo-Benzyl-Guanidine (MIBG) for Patients with MIBG Avid Pulmonary Carcinoid Tumors. Journal of Thoracic Oncology. 10:S633-S633.